APA

Auderset F., Ballester M., Mastelic-Gavillet B., Fontannaz P., Chabaud-Riou M., Reveneau N., Garinot M., Mistretta N., Liu Y., Lambert P., Ochs M. & Siegrist C. (20201021). Reactivating Immunity Primed by Acellular Pertussis Vaccines in the Absence of Circulating Antibodies: Enhanced Bacterial Control by TLR9 Rather Than TLR4 Agonist-Including Formulation. : Frontiers in immunology.

Chicago

Auderset Floriane, Ballester Marie, Mastelic-Gavillet Beatris, Fontannaz Paola, Chabaud-Riou Martine, Reveneau Nathalie, Garinot Marie, Mistretta Noëlle, Liu Yuanqing, Lambert Paul-Henri, Ochs Martina and Siegrist Claire-Anne. 20201021. Reactivating Immunity Primed by Acellular Pertussis Vaccines in the Absence of Circulating Antibodies: Enhanced Bacterial Control by TLR9 Rather Than TLR4 Agonist-Including Formulation. : Frontiers in immunology.

Harvard

Auderset F., Ballester M., Mastelic-Gavillet B., Fontannaz P., Chabaud-Riou M., Reveneau N., Garinot M., Mistretta N., Liu Y., Lambert P., Ochs M. and Siegrist C. (20201021). Reactivating Immunity Primed by Acellular Pertussis Vaccines in the Absence of Circulating Antibodies: Enhanced Bacterial Control by TLR9 Rather Than TLR4 Agonist-Including Formulation. : Frontiers in immunology.

MLA

Auderset Floriane, Ballester Marie, Mastelic-Gavillet Beatris, Fontannaz Paola, Chabaud-Riou Martine, Reveneau Nathalie, Garinot Marie, Mistretta Noëlle, Liu Yuanqing, Lambert Paul-Henri, Ochs Martina and Siegrist Claire-Anne. Reactivating Immunity Primed by Acellular Pertussis Vaccines in the Absence of Circulating Antibodies: Enhanced Bacterial Control by TLR9 Rather Than TLR4 Agonist-Including Formulation. : Frontiers in immunology. 20201021.